The 340B Program started in 1992. It is run by the Health Resources and Services Administration’s Office of Pharmacy Affairs. This program makes drug makers sell outpatient drugs at lower prices to certain hospitals and health centers. These places include government and nonprofit hospitals, community health centers, children’s hospitals, and other providers who serve low-income or uninsured people.
The idea is to help these organizations save money. They get drugs for less than the usual price. This helps them serve more patients and provide better care. The savings help support programs for communities that need it most.
Some covered entities do not just use their own pharmacies. They make agreements with outside pharmacies called contract pharmacies. These pharmacies help give 340B-priced drugs to patients. This can be at local retail, community, or specialty pharmacies.
About 80% of rural hospitals in the 340B Program use contract pharmacies. This helps patients get needed medicine close to where they live. It is especially important where hospitals do not have their own pharmacies. Contract pharmacies also help patients stick to their medicine schedules by offering local and mail order services.
But using contract pharmacies adds more rules and paperwork. Covered entities must watch carefully to follow the rules and stop abuses like giving drugs to people who are not eligible or getting double discounts.
Since 2020, some drug makers have added rules for contract pharmacies. They want to reduce risks like drug diversion and double discounts. These rules can require special verification of prescriptions or limit which pharmacies can take part in 340B contracts.
These new rules have caused money losses for hospitals that serve safety-net communities. For example, critical access hospitals lose about $500,000 each year. Larger hospitals lose nearly $3 million yearly due to these restrictions.
The Department of Health and Human Services and HRSA have spoken against these actions. They said manufacturers must offer 340B prices for drugs given by contract pharmacies, no matter where the drug is delivered. Some states like Arkansas, Louisiana, Minnesota, and Missouri have passed laws to protect contract pharmacy access under the 340B Program.
HRSA does about 200 audits each year to keep the program honest and stop misuse. Covered entities must follow rules on registration, oversight, and reporting to keep their place in the 340B Program.
The 340B Program is an important source of money for many hospitals and clinics in underserved areas. Government reports say savings range from 20% to 50% off drug prices. In 2018, the program saved about $67.9 billion for covered entities.
More than half of eligible hospitals are in rural places where healthcare is hard to get. Contract pharmacies help these hospitals reach patients and give medicine on time.
Companies like VytlOne have helped many health systems earn over $500 million since 2019. They do this by improving tracking, audit readiness, and program management even when there are manufacturer restrictions.
Programs like bedside prescription delivery have shown results. Some health systems saw a 125% rise in pharmacy revenues and a 79% drop in hospital readmissions.
Rules for the 340B Program and contract pharmacies have become more complex. This makes many healthcare leaders look for better ways to work. Artificial intelligence (AI) and automation are now used to make compliance easier and more accurate.
Healthcare IT managers can benefit a lot by using these technologies. They reduce paperwork and build stronger compliance systems. Companies like Simbo AI offer phone and answering services that help with patient questions, prescription handling, and pharmacy work.
Medical practice administrators, owners, and IT staff who manage 340B contract pharmacy arrangements need to know these complex rules well. They must update pharmacy registrations, keep Medicaid carve-outs correct, do audits, and stop billing mistakes. All this takes time and skill.
Using AI-driven automation makes work more reliable and easier to track. Data reports in real time help choose buying strategies that follow program rules. This lowers money risks from misuse or manufacturer restrictions.
As legal and regulatory rules tighten, strong oversight stays very important. Technology tools can help meet these challenges. This keeps patient access to low-cost medicine safe and protects the practice from money and legal problems.
The 340B Drug Pricing Program allows eligible covered entities to purchase outpatient drugs at discounted prices to extend federal resources, enabling them to reach more patients and provide comprehensive services.
A contract pharmacy arrangement allows covered entities to dispense 340B drugs through external pharmacies. To be compliant, these arrangements must meet the requirements outlined by the HRSA.
The written contract must specify all pharmacy locations involved in the arrangement and must be finalized and signed before registration with the Office of Pharmacy Affairs (OPA).
Contract pharmacies must register with the OPA before dispensing 340B drugs. Both the covered entity and the pharmacy must sign the Contract Pharmacy Registration Form to be recognized.
If a contract pharmacy changes ownership, the covered entity must submit a new registration with the OPA and terminate the old registration to continue the arrangement legally.
Contract pharmacies may not dispense 340B drugs to Medicaid patients unless an arrangement is established to prevent duplicate discounts, which must be reported to the OPA.
Covered entities must perform vigilant oversight of their contract pharmacies, ensuring compliance with 340B requirements and conducting independent audits at least annually.
HRSA audits check for written agreements, timely registration of contract pharmacies, oversight evidence, written policies on compliance, and evidence of actual pharmacy utilization.
Non-compliance can lead to financial penalties, loss of eligibility for the program, and potential audits that could uncover irregularities in the distribution of 340B drugs.
Covered entities can seek assistance from ApexusAnswers, a service of the 340B contracted Prime Vendor Program, via their website or by contacting them through phone or email.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
